Australija - engleski - Department of Health (Therapeutic Goods Administration)

evergrowth pty ltd - propolis resin, quantity: 200 mg/ml (equivalent: lead, qty 2 microgram/ml; equivalent: propolis, qty 300 mg/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; decrease/reduce/relieve symptoms of mild mouth ulcers ; traditionally used in chinese medicine to decrease/reduce/relieve mild throat inflammation ; traditionally used in western herbal medicine to decrease/reduce/relieve mild throat inflammation ; decrease/reduce/relieve mild throat inflammation ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of mild throat infection ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild throat infection ; decrease/reduce/relieve throat mucous membrane irritation/inflammation ; helps decrease/reduce/relieve symptoms of minor skin wounds (cuts, scratches and abrasions) ; traditionally used in western herbal medicine to maintain/support wound healing ; traditionally used in chinese medicine to maintain/support wound healing

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) - oral suspension - 1e+006 ccid50 - active: live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) excipient: di-sodium adipate dulbecco's modified eagle medium sucrose water for injection - rotarix is indicated for the prevention of rotavirus gastroenteritis

Australija - engleski - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus -

Novi Zeland - engleski - Ministry for Primary Industries

zoetis new zealand limited - carprofen - carprofen 20 g/litre - anti-inflammatory

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefaclor monohydrate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefaclor monohydrate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 4000 mg - liquid, multipurpose - excipient ingredients: monobasic sodium phosphate monohydrate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1- antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 500 mg - liquid, multipurpose - excipient ingredients: monobasic sodium phosphate monohydrate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1- antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

rainey chiropractic, inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838) - for epigenetic support. for epigenetic support.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mannitol; sucralose; carmellose calcium - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.